Annual Cash & Cash Equivalents
$249.11 M
+$196.76 M+375.84%
December 31, 2023
Summary
- As of February 26, 2025, FDMT annual cash & cash equivalents is $249.11 million, with the most recent change of +$196.76 million (+375.84%) on December 31, 2023.
- During the last 3 years, FDMT annual cash & cash equivalents has fallen by -$27.62 million (-9.98%).
- FDMT annual cash & cash equivalents is now -9.98% below its all-time high of $276.73 million, reached on December 31, 2020.
Performance
FDMT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$187.54 M
-$1.52 M-0.81%
September 30, 2024
Summary
- As of February 26, 2025, FDMT quarterly cash and cash equivalents is $187.54 million, with the most recent change of -$1.52 million (-0.81%) on September 30, 2024.
- Over the past year, FDMT quarterly cash and cash equivalents has dropped by -$88.14 million (-31.97%).
- FDMT quarterly cash and cash equivalents is now -32.23% below its all-time high of $276.73 million, reached on December 31, 2020.
Performance
FDMT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
FDMT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +375.8% | -32.0% |
| 3 y3 years | -10.0% | -32.0% |
| 5 y5 years | +171.5% | -32.0% |
FDMT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +375.8% | -32.0% | +258.2% |
| 5 y | 5-year | -10.0% | +401.7% | -32.2% | +277.7% |
| alltime | all time | -10.0% | +944.5% | -32.2% | +277.7% |
4D Molecular Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $187.54 M(-0.8%) |
| Jun 2024 | - | $189.06 M(-31.4%) |
| Mar 2024 | - | $275.59 M(+10.6%) |
| Dec 2023 | $249.11 M(+375.8%) | $249.11 M(-9.6%) |
| Sep 2023 | - | $275.68 M(+16.7%) |
| Jun 2023 | - | $236.31 M(+200.8%) |
| Mar 2023 | - | $78.57 M(+50.1%) |
| Dec 2022 | $52.35 M | $52.35 M(-51.7%) |
| Sep 2022 | - | $108.30 M(-4.6%) |
| Jun 2022 | - | $113.48 M(+49.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $75.97 M(-50.3%) |
| Dec 2021 | $153.00 M(-44.7%) | $153.00 M(+68.2%) |
| Sep 2021 | - | $90.99 M(-62.7%) |
| Jun 2021 | - | $243.74 M(-6.2%) |
| Mar 2021 | - | $259.87 M(-6.1%) |
| Dec 2020 | $276.73 M(+457.3%) | $276.73 M(+211.8%) |
| Sep 2020 | - | $88.75 M(+78.8%) |
| Dec 2019 | $49.65 M(-45.9%) | $49.65 M(-31.9%) |
| Jun 2019 | - | $72.87 M(-20.6%) |
| Dec 2018 | $91.76 M(+284.7%) | $91.76 M |
| Dec 2017 | $23.85 M | - |
FAQ
- What is 4D Molecular Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual cash & cash equivalents year-on-year change?
- What is 4D Molecular Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly cash and cash equivalents year-on-year change?
What is 4D Molecular Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of FDMT is $249.11 M
What is the all time high annual cash & cash equivalents for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual cash & cash equivalents is $276.73 M
What is 4D Molecular Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, FDMT annual cash & cash equivalents has changed by +$196.76 M (+375.84%)
What is 4D Molecular Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of FDMT is $187.54 M
What is the all time high quarterly cash and cash equivalents for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly cash and cash equivalents is $276.73 M
What is 4D Molecular Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, FDMT quarterly cash and cash equivalents has changed by -$88.14 M (-31.97%)